BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36805278)

  • 1. Does ferritin level affect the outcomes of autologous stem cell transplantation equally in all diseases?
    Uysal A; Erkurt MA; Kuku İ; Kaya E; Sarıcı A; Berber İ; Biçim S; Hidayet E; Kaya A; Arslan S; Cırık S
    Transfus Apher Sci; 2023 Jun; 62(3):103655. PubMed ID: 36805278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
    Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
    BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload.
    Sivgin S; Karamustafaoglu MF; Yildizhan E; Zararsiz G; Kaynar L; Eser B; Cetin M; Unal A
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S152-8. PubMed ID: 27521313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1239-44. PubMed ID: 18940678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
    J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation.
    Wang X; Ren J; Liang X; He P
    Hematology; 2021 Dec; 26(1):950-955. PubMed ID: 34904529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.
    Tan XN; Yew CY; Ragg SJ; Harrup RA; Johnston AM
    Intern Med J; 2022 Jul; 52(7):1242-1250. PubMed ID: 33949777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.
    Hwang DY; Kim SJ; Cheong JW; Kim Y; Jang JE; Lee JY; Min YH; Yang WI; Kim JS
    Leuk Lymphoma; 2016; 57(1):51-7. PubMed ID: 25899401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
    Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Related Factors of Autologous Peripheral Hematopoietic Stem Cell Mobilization in Patients with Lymphoma and Myeloma].
    Yu XQ; Wang LX; Lei F; Lu WP; Fei XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1861-1867. PubMed ID: 36476917
    [TBL] [